Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 30 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

37%

11 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

Phase 4
11(78.6%)
N/A
2(14.3%)
Phase 2
1(7.1%)
14Total
Phase 4(11)
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT05673824Phase 2Completed

Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.

Role: collaborator

NCT05871437Phase 4Not Yet Recruiting

Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules

Role: collaborator

NCT05660213Not Yet Recruiting

A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer

Role: collaborator

NCT04263922Phase 4Recruiting

Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

Role: collaborator

NCT04790305Phase 4Recruiting

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Role: collaborator

NCT05498766Phase 4Not Yet Recruiting

Effect and Safety of Huaier Granule Versus SOX Regimen in Gastric Cancer Patients

Role: collaborator

NCT05772871Phase 4Recruiting

The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children

Role: collaborator

NCT05839314Phase 4Recruiting

Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

Role: collaborator

NCT04641819Phase 4Active Not Recruiting

Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients

Role: collaborator

NCT06109454Recruiting

Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery

Role: collaborator

NCT06368063Phase 4Recruiting

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Role: collaborator

NCT06387368Phase 4Not Yet Recruiting

Clinical Study of Huaier Granule in the Treatment of Unresectable Pancreatic Cancer

Role: collaborator

NCT04401059Phase 4Recruiting

Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC:Prospective Study

Role: collaborator

NCT04397432Active Not Recruiting

Synergistic Effect of Elemene Plus TKIs Compared With TKIs in EGFR-mutated Advanced NSCLC:Retrospective Study

Role: collaborator

NCT05860907Phase 4Not Yet Recruiting

Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis

Role: collaborator

NCT03735511Unknown

A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma

Role: collaborator

NCT03787953Unknown

A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors

Role: collaborator

NCT03283124Not ApplicableUnknown

Comparing Transvaginal Self-tailored Titanium-coated Polypropylene Mesh Procedure With Mesh-kit Procedure.

Role: collaborator

NCT03849157Not ApplicableUnknown

RCT for Transvaginal Self-cut Mesh vs Mesh-kit for Severe POP

Role: collaborator

NCT03631459Unknown

A Multicenter Real World Study of Kanglaite for Cancer Cachexia

Role: collaborator